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Aspirin and Emotion 
Abstract 
The over-the-counter, pain-relieving drugs acetaminophen and ibuprofen have previously 
been shown to have effects on emotion. Specifically, these drugs cause the blunting of 
evaluations and reactions to both positive and negative stimuli (Durso, Luttrell, & Way, 2015; 
Keaveney, Peters, & Way, under review). In order to identify the biochemical mechanism 
underlying these emotion blunting effects, we proposed to study the effects of the drug Aspirin. 
These drugs all produce their pain relieving effects by inhibiting the cyclooxygenase (COX) 
enzyme. However, there are two different isoforms of the enzyme: cyclooxygenase 1 (COX-1) 
and cyclooxygenase 2 (COX-2). Acetaminophen primarily inhibits COX-2 while ibuprofen is 
non-selective. Therefore, it is currently unclear whether emotion blunting effects are specific 
only to the COX-2 isoform, or if both isoforms contribute. The drug Aspirin is also a COX 
inhibiting drug; however, Aspirin is COX-1 selective. To test whether emotion blunting effects 
are primarily influenced by COX-2 inhibition, we tested if a 500mg pain-relieving dose of 
Aspirin influenced responses to psychological tasks. 135 male participants (mean age: 19.20; 
58% White, 22% Asian, 5% African American, 4% Hispanic, 9% Multiracial/Other) were 
randomly assigned to either Aspirin or placebo groups. After 60 minutes of uptake time, 
participants completed two tasks designed to measure response to and memory of emotional 
stimuli, respectively. In the first task, participants rated 60 emotionally evocative images for 
valence (i.e. evaluations) and 60 emotionally evocative images for arousal (i.e. emotional 
reaction). After a 5-minute distractor task, participants completed a memory task where they 
were re-presented with 45 images from the prior task as well as 135 new images, in order to 
determine if Aspirin blunted the enhanced recognition of emotional images. Participants 
indicated whether each image had been previously viewed in the original task or was a new 
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image. In contrast to the original hypothesis, Aspirin increased reactions to the negative stimuli 
and increased overall memory recognition, with the latter effects approaching statistical 
significance. These results could suggest that COX-1 and COX-2 potentially have opposite roles 
in emotional responses, with the inhibition of COX-1 causing emotion enhancement (at least 
towards negative stimuli) and COX-2 inhibition causing emotion blunting. 
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Introduction 
Acetaminophen is found in over 600 medicines and is the active ingredient in the over-
the-counter pain-relieving drug Tylenol. It is the most popular over-the-counter form of pain 
relief in the United States, taken by an estimated 50 million Americans each week (Kaufman, 
Kelly, Rosenberg, Anderson, & Mitchell, 2002). In addition to these pain-relieving effects, 
recent research has shown that acetaminophen also blunts responses to both negative and 
positive emotional images (Durso, Luttrell, & Way, 2015). Further research on another over-the-
counter pain-reliever, ibuprofen (Advil), has shown similar emotion blunting effects (Durso, 
Keaveney, & Way, in preparation). These drugs work by inhibiting the enzyme cyclooxygenase 
(COX), which synthesizes inflammation causing prostaglandins and platelet aggregation causing 
thromboxanes (Vane, 2002). However, cyclooxygenase comes in two isoforms: COX-1 and 
COX-2. Acetaminophen is a preferential COX-2 inhibitor while ibuprofen inhibits both COX-1 
and COX-2 isoforms to a similar degree (Warner et al, 1999). It is currently unknown whether 
the emotion blunting effects caused by these drugs are due to a specific subtype of the enzyme or 
not. Based on our previous acetaminophen research, a strong case can be made for the role of 
COX-2 in emotion blunting. The role of COX-1, however, is less clear; since ibuprofen inhibits 
both COX1-1 and COX-2, we cannot separate out the effects of COX-1. In order to clarify 
whether emotion blunting effects are subtype specific or not, we therefore decided to test a COX-
1 specific inhibitor for potential emotion blunting effects.  
Acetylsalicylic acid, commonly known as Aspirin, is a pain-relieving, anti-inflammatory 
drug, in use for nearly a century and a half, and is the most commonly used drug in the world 
(Vane, 2002). It is one in a group of drugs known as non-steroidal anti-inflammatory drugs 
(NSAID) that are used for pain relief and a wide range of illnesses. The mechanism of action for 
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Aspirin’s anti-inflammatory and anti-platelet effects was not identified until 1971, nearly a 
century after its discovery (Vane, 1971). It works by irreversibly inhibiting COX-1 and only has 
small effects on COX-2, primarily at high doses (Warner et al., 1999). Thus, because of 
Aspirin’s selectivity in inhibiting COX-1, studying the effects of this drug on emotion could help 
clarify the role of the cyclooxygenases in emotions. In addition to these theoretical reasons, it is 
important to study the effects of Aspirin on emotion because of its wide-spread usage where any 
side effects could have widespread impact. 
In addition to its pain-relieving effects when administered at high doses (350-500 mg), 
low-dose Aspirin (80mg) is taken daily by millions of people each year to help in the prevention 
of cardiovascular disease (CVD), leading to a reduction in stroke and myocardial infarctions in 
patients with a history of these issues (Guirguis-Blake, 2015). The positive effects of Aspirin on 
CVD come from Aspirin’s ability to inhibit the production of thromboxanes that contribute to the 
disease. There is also emerging evidence that Aspirin may be helpful in prevention of cancer 
relapse, particularly for colorectal cancer (Chan, 2012). Based on the success of these initial 
trials, multiple clinical trials of Aspirin to prevent relapse of other forms of cancer have been 
initiated (Thorat and Cuzick, 2013). If successful, these could lead to an even more widespread 
use of Aspirin. Since Aspirin is already the most commonly used drug in the world and new 
applications for the drug are still emerging, it is important to study whether the drug may be 
having psychological effects in addition to these effects on cancer and cardiovascular disease. 
Clinical trials have indeed shown that Aspirin may be having psychological effects in 
addition to its physiological effects, specifically in the domain of emotion. In fact, studies 
looking at the potential beneficial effects Aspirin may have on depressive symptoms date back to 
the 1990’s (Ketterer, 1996). One recent, small study has shown that Aspirin has beneficial effects 
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on depressed mood in the context of bereavement. In the study, not only did the bereaved 
patients on Aspirin report fewer depressive symptoms upon a second visit than the bereaved 
group not taking Aspirin, but the Aspirin group also had a significantly larger decrease in heart 
rate after undergoing a separation recognition task compared to placebo (Karl, 2018). Recent 
studies on Aspirin’s effect on bipolar disorder have also shown that Aspirin may enhance 
remission rate. In one randomized controlled trial of patients with bipolar disorder, it was found 
that Aspirin led to better response rates than placebo (Savitz, 2018). Since bipolar disorder is 
characterized by periods of extremely positive emotion in addition to extremely negative 
emotion, this suggests that Aspirin’s emotion altering effects may not be limited to just negative 
emotions. Taken together, these studies suggest the novel hypothesis that Aspirin may be having 
effects on both positive and negative emotions.  
This thesis will test if the COX-1 inhibitor Aspirin will blunt responses to emotional 
stimuli in the same manner as acetaminophen and ibuprofen. If results are positive, this would 
implicate both COX-1 and COX-2 in emotional reactivity. If results are negative, this would 
imply that COX-2, but not COX-1, is responsible for the emotion blunting effects of these over-
the-counter drugs.  
As an additional test of the effects of Aspirin on emotionality, participants completed a 
second task. There have been robust findings that people have a greater ability to recognize 
emotionally salient images and experiences (Leal et al., 2014; Buchanan & Lovallo, 2001). If 
Aspirin is in fact blunting reactions to positive and negative stimuli, then it follows that it may 
reduce the enhanced recognition of these emotionally salient images, as well. Therefore, a 
memory recognition task was also implemented in order to assess any effects Aspirin may have 
on the memory recognition of emotionally salient images.   
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Methods 
Participants. 135 male participants (mean age: 19.20; 58% White, 22% Asian, 5% 
African American, 4% Hispanic, 9% Multiracial/Other) were recruited in exchange for course 
credit. Women, anyone with a blood coagulation disorder, those at higher risk for intestinal 
bleeding, and other high-risk groups were not included in the experiment based on safety 
concerns. 
Drug. Capsules containing 500mg Aspirin and identical capsules packed with 500mg 
microcrystalline cellulose were prepared by Pharmacy Specialists (www.makerx.com), a 
licensed compounding pharmacy. 
Procedure. Participants were randomly assigned to either placebo or 500 mg of Aspirin 
in a double-blind procedure. Participants were assigned to a personal cubicle where they took 
either the drug or placebo and then began to fill out background demographic and personality 
questionnaires (See Appendix for complete questionnaires), which took participants 
approximately 20-30 minutes to complete. The tasks were not begun until 60 minutes had passed 
from drug or placebo intake, in order allow sufficient time for Aspirin to be absorbed into the 
brain (Cryer, 1998; Nagelschmitz, 2014). 
Emotional Image Rating Task: Each participant was presented with 120 images, drawn 
from the previously published stimuli used in Leal et al. (2014), Schaller (2011) and the 
International Affective Picture System (Lang, 1995), in a pseudo-random order according to the 
procedures in Durso et al. (2015). Images were pre-categorized on evaluative dimensions 
corresponding to extremely unpleasant (35 images), moderately unpleasant (15 images), neutral 
(20 images), moderately pleasant (15 images), and extremely pleasant (35 images). The 
participants were asked to evaluate 60 of the images on their valence by being asked the 
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question: “To what extent is this picture positive or negative?” using a 9-point scale with 4 being 
extremely positive, -4 being extremely negative, and 0 being neither positive nor negative. They 
were then shown 60 different images, this time being asked: “To what extent does this picture 
make you feel an emotional reaction?” in order to rate their level of emotional arousal. A similar 
9-point scale was used, with 0 being “I feel little emotion” and 8 being “I feel an extreme amount 
of emotion.” These two blocks were in a consecutive, non-counterbalanced order.  
Memory Recognition Task: After completing an approximately 5-minute distractor task,  
participants were then asked to perform a memory recognition task based on the paradigm in 
Leal et al. (2014). Participants were shown 180 images and had to classify each as an image that 
they had seen in the emotional rating task or a new image. Images were divided equally among 
four different groups: 45 old images that appeared in the emotional rating task, 45 new high 
similarity lures that looked very closely like images shown in the emotional rating task (ex. an 
image of a crossing guard, after being shown an image of the same crossing guard from a slightly 
different angle in the first task), 45 new low similarity lures that looked somewhat like images 
shown in the emotional rating task (ex. an image of a dirty stall, after being shown an image of a 
dirty toilet in the first task), and 45 new foils that did not bare any resemblance to images from 
the emotional rating task (ex. an image of an airplane, after not being shown an image of aircraft 
in the first task). Each group was evenly composed of 9 images from each extremely unpleasant, 
moderately unpleasant, neutral, moderately pleasant, and extremely pleasant image category. For 
analysis, d-prime (d’) scores were then calculated for each participant in each normative rating 
category. d’ is a measure of a participant’s signal detection ability and is unaffected by response 
bias. It was calculated by subtracting the z-score of each participant’s hit rate by the z-score of 
their false alarm rate for each normative rating category.     
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Saliva Sample: Participants were asked to provide two saliva samples of 1.5 mL in order 
to measure prostaglandin levels in the saliva. Saliva samples were taken at the beginning of the 
experiment 5 minutes after the ingestion of drug or placebo, and at the end of the experiment 
after participants had completed all computerized tasks, approximately 90 minutes after ingestion 
of drug or placebo.   
Results 
 At the end of the study, participants indicated whether they thought they took Aspirin or 
placebo without the option to say that they did not know. A chi-square test of independence was 
performed to examine whether actual treatment predicted participants’ perceived treatment. A 
chi-square test of independence yielded a nonsignificant result, χ2(1, N = 135) = 0.671, p = 
0.413. Specifically, 55% of participants who guessed that they took Aspirin were actually in the 
placebo condition and 52% of participants who guessed they took placebo were actually in the 
Aspirin condition.  
An a priori defined reaction time, < 500 msec, was deemed to indicate that the 
participant was not taking the study seriously. Thus, 3 participants were excluded from the 
analyses of evaluation ratings for having >3 trials under 500 msec, 9 participants were excluded 
from the analyses of emotional reaction ratings for having >3 trials under 500 msec, and 11 
participants were excluded from the analyses of memory recognition for having >10 trials under 
500 msec. The qualitative nature of the results was unchanged. 
Evaluations: Because prior work on acetaminophen found that there was an overall 
reduction in evaluation extremity irrespective of the valence of the stimulus, the extremity of 
evaluations for the Aspirin and placebo groups were compared. For the 132 participants who 
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completed the study at the time of analysis, evaluation extremity (absolute value of the distance 
from the midpoint) to all stimuli was submitted to an independent-samples t-test, with treatment 
as the between-participants factor. There was no significant difference in evaluation extremity 
between the Aspirin (M = 1.675, SD = 0.426) or placebo (M = 1.624, SD = 0.413) groups, t(130) 
= 0.702, p = 0.484 (Fig. 1). 
 
Fig 1. Mean evaluation extremity as a function of treatment condition. Evaluation extremity was indexed by 
calculating the mean rating of stimuli and then determining the distance of that rating from the scale midpoint. Error 
bars represent 95% confidence intervals. 
 
Next, to determine if the effect of Aspirin was different as a function of the valence of the 
stimulus, participants’ raw evaluations were then submitted to a 2 (treatment: Aspirin, placebo) × 
5 (normative rating: extremely unpleasant, moderately unpleasant, neutral, moderately pleasant, 
extremely pleasant) mixed-model ANOVA. Mauchly’s test indicated that the assumption of 
sphericity had been violated, χ2(9) = 181.806, p < .001. Because the epsilon value was less than 
or equal to 0.75 (ε = 0.549), degrees of freedom were corrected using Greenhouse-Geisser 













































Mean of Overall Extremity by Drug Condition
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1471.445, p < .001, ηp2 = 0.919. As expected, participants rated extremely unpleasant pictures 
more negatively and extremely pleasant pictures more positively in a linear fashion, consistent 
with normative ratings of the stimuli. The main effect of treatment was close to, but did not meet, 
significance, F(1,130) = 2.792, p = 0.097, ηp2 = 0.996. The Aspirin condition had lower ratings 
(M = 5.021 SD = 0.043) than the placebo condition (M = 5.121 SD = 0.042). The interaction of 
normative rating and drug condition was non-significant, F(2.141, 278.332) = 1.461, p = 0.233, 
ηp2 = 0.011 (Fig 2).  
 
Fig 2. Mean evaluation of stimuli as a function of normative-rating category and treatment condition. Error bars 
represent 95% confidence intervals. 
 
Contrast analyses showed that participants who took Aspirin rated neutral stimuli (M = 
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who received placebo (M = 5.210, SD = 0.065). Participants who took Aspirin (M = 3.757, SD = 
0.084) also tended to rate moderately unpleasant images more negatively compared with 
participants who received placebo (M = 3.900, SD = 0.083), t(130) = -1.205, p = 0.230. 
Additionally, participants who took Aspirin (M = 2.309, SD = 0.069) tended to rate extremely 
unpleasant images more negatively than participants on placebo (M = 2.450, SD = 0.068), t(130) 
= -1.471, p = 0.144. However, both of these differences were not statistically significant. 
Emotional Arousal: Because prior work on acetaminophen found that there was an 
overall reduction in emotional arousal irrespective of the valence of the stimulus, the overall 
arousal for the Aspirin and placebo groups were compared. Participants’ overall emotional 
arousal to all stimuli was submitted to an independent-samples t-test, with treatment as the 
between-participants factor. Results showed no difference in emotional arousal between the 
Aspirin (M = 3.952, SD = 1.215 ) and placebo (M = 3.966, SD = 1.085) groups, t(124) = -0.67, p 
= 0.947 (Fig 3).   
 
Fig 3. Mean rating of emotional arousal toward all stimuli as a function of treatment condition. Error bars represent 


























Overall Arousal by Drug Condition
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Next, we submitted participants’ emotional arousal ratings within each of the five 
normative categories to the same 2 × 5 mixed-model ANOVA used to analyze their evaluations. 
Mauchly’s test indicated that the assumption of sphericity had been violated, χ2(9) = 54.432, p < 
.001, so degrees of freedom were corrected using Huynh-Feldt estimates of sphericity (ε = 
0.883). A main effect of normative rating was obtained, F(3.530, 437.722) = 253.085, p < .001, 
ηp2 = 0.671. Specifically, participants expressed higher emotional arousal toward stimuli that 
were normatively more extreme in valence, with the highest arousal toward extremely unpleasant 
and extremely pleasant stimuli, and the lowest arousal toward neutral stimuli. There was no main 
effect of drug condition, F(1, 124) = 0.004, p = 0.947, ηp2 < 0.001. The interaction of normative 
category and drug condition was close to, but did not reach, significance, F(3.530, 437.722) = 
2.363, p = 0.060, ηp2 = 0.019 (Fig 4).  
 
Fig 4. Mean rating of emotional arousal toward stimuli as a function of normative rating category and treatment 
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Contrast analyses indicated that participants who received Aspirin tended to rate 
moderately unpleasant stimuli (M = 3.577, SD = 0.194) as more arousing than participants on 
placebo (M = 3.230, SD = 0.191) , t(124) = 1.272, p = 0.206. Participants on Aspirin rated 
moderately pleasant images (M = 4.317, SD = 0.200) as less arousing than participants on 
placebo (M = 4.648, SD = 0.197) , t(124) = -1.181, p = 0.240. These results did not reach 
statistical significance. Further, participants on Aspirin tended to rate extremely unpleasant 
images (M = 4.953, SD = 0.176) as more arousing than participants on placebo (M = 4.845, SD = 
0.173), t(124) = 0.442, p = 0.659, and extremely pleasant images (M = 5.051, SD = 0.198) as less 
arousing than participants on placebo (M = 5.139, SD = 0.195), t(124) = 0.442, p = 0.725. These 
results, however, were non-significant.     
 Memory Recognition: One of the goals of this task was to determine if Aspirin decreased 
the emotional enhancement of memory, so the first thing we wanted to establish is if there was 
an emotional enhancement of memory effect irrespective of drug condition. Participant’s d’ 
scores were submitted to a paired samples t-test to compare overall recognition of neutral images 
and extremely unpleasant images. Extremely unpleasant images had a significantly higher 
recognition than neutral images, t(123) = 4.31, p < 0.0001 (Fig 5). 
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Fig 5. Average d’ scores in the extremely unpleasant and neutral categories for all participants.  
Participants’ overall average d’ scores were then submitted to an independent-samples t-
test, with treatment as the between-participants factor in order to determine of there was an effect 
of drug condition. Results showed no significant difference between the average recognition of 














Average of Extremely Unpleasant and Neutral d' Scores
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Fig 6. Mean d’ score for all stimuli as a function of treatment condition. Error bars represent 95% confidence 
intervals. 
 
We then submitted participants’ d’ scores as categorized by their neutral, moderate, or 
extreme normative ratings to a 2 (treatment: Aspirin, placebo) × 3 (image category: neutral, 
moderate, or extreme) mixed-model ANOVA, with treatment as a between-participants factor 
and image category as a within-participants factor. Mauchly’s test indicated that the assumption 
of sphericity had been violated, χ2(2) = 7.989, p = 0.018, so degrees of freedom were corrected 
using Huynh-Feldt estimates of sphericity (ε = 0.962). A main effect of extremity was found, 
F(1.924, 234.723) = 10.657, p < 0.001, ηp2 = 0.080. Specifically, moderate images had the 
lowest recognition (M = 2.587, SD = 0.045), followed by neutral images (M = 2.646, SD = 
0.045), and then extreme images with the greatest recognition (M = 2.773, SD = 0.040). There 
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interaction between extremity and drug condition, F(1.924, 234.723) = 1.294, p = 0.275, ηp2 = 
0.010 (Fig 7).  
 
Fig 7. Mean d’ score of all stimuli as a function of image category (collapsed across valence) and treatment 
condition. Error bars represent 95% confidence intervals. 
 
Finally, participants’ d’ scores within each of the five normative categories were 
submitted to the same 2 × 5 mixed-model ANOVA used to analyze their evaluations and 
emotional arousal. Mauchly’s test indicated that the assumption of sphericity had been violated, 
χ2(9) = 17.198, p < .046, so degrees of freedom were corrected using Huynh-Feldt estimates of 
sphericity (ε = 0.975). Results showed a main effect of image category, F(3.900, 475.826) = 
15.931, p < 0.001, ηp2 = 0.115 . Specifically, participants  had the least recognition for 
moderately unpleasant images, followed by neutral, extremely pleasant, moderately pleasant, and 
then extremely unpleasant images, which were recognized the best. There was a close to, but 
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normative category and drug condition, F = (3.900, 475.826) = 0.850, p = 0.492, ηp2 = 0.007 
(Fig 8).    
 
Fig 8. Mean d’ score of all stimuli as a function of normative-rating category and treatment condition. Error bars 
represent 95% confidence intervals. 
 
Contrast analyses showed that participants who took Aspirin had a significantly better 
recognition of moderate images (M = 2.678, SD = 0.064) than participants who took placebo (M 
= 2.495, SD = 0.062), t(122) = 2.061, p = 0.041. Though the difference in recognition of 
moderately pleasant (Aspirin: M = 2.804, SD = 0.072; placebo: M = 2.628, SD = 0.069), 
t(100.361) = 1.795, p = 0.076, and moderately unpleasant (Aspirin: M = 2.553, SD = 0.078; 
placebo: M = 2.362, SD = 0.076), t(122) = 1.765, p = 0.080, images were not statistically 
significant on their own. Participants who took Aspirin had no significant difference in the 
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SD = 0.055), t(99.135) = 1.084, p = 0.281. However, there was a greater difference between 
Aspirin (M = 2.905, SD = 0.062) and placebo (M = 2.786, SD = 0.060) in the extremely 
unpleasant category t(103.877) = 1.397, p = 0.165, than in the extremely pleasant category 
(Aspirin: M = 2.786, SD = 0.068; placebo: M =2.676, SD = 0.066), t(105.880) = 0.535, p = 
0.593.   
Correlation and Mediation Analyses: In order to determine if there was a relationship 
between emotional ratings and memory recognition, specifically if images rated as more 
emotional were remembered better, a correlation analysis was performed. For extremely 
unpleasant stimuli, there was a significant correlation between evaluations and d’, r(122) = 
0.181, p = 0.046, but there was not a relationship for the arousal ratings and d', r (120) = 0.026, p 
= 0.777. There was not a relationship between d' and evaluations or arousal ratings for any of the 
other categories of stimuli,  (p's > .200). 
 Finally, to determine if the relationship between Aspirin and memory (i.e. d’) for the 
extremely unpleasant stimuli was explained by the magnitude of self-reported evaluations or 
arousal, a mediation analysis was performed using Model 4 in the PROCESS macro for SPSS 
(Hayes, 2012) with 5000 bootstrapping samples to construct bias-corrected 95% confidence 
intervals. The indirect effect of drug condition on d’ was not significant for evaluations (-.0176, 
.0605 ) or arousal (-.0185, .0128). 
 Saliva Samples: Saliva samples are yet to be analyzed, but we expect to find a decrease in 
prostaglandin levels between the first and second sample in the Aspirin group. Additionally, we 
expect to see no difference between the first and second sample in the placebo group. This 
salivary assay will confirm drug effectiveness.  
21 
Aspirin and Emotion 
Discussion 
 Prior work has shown that the effect size of acetaminophen on emotional reactions is 
around a d of 0.4, which indicates that a samples size of 200 individuals is necessary to have the 
desired power of 0.8 to detect a significant effect. Thus, the originally intended goal in our 
preregistration (clinicaltrials.gov: NCT04146532). Therefore, this study is currently 
underpowered due to our insufficient sample size. Experimentation had to be ended early due to 
the outbreak of COVID-19, and as a result further participants cannot be run for an undetermined 
amount of time. While precise conclusions cannot be made at this time due to our small sample 
size, potentially interesting trends are emerging in the data. Though most analyses failed to reach 
significance, some came close to it and they offer us interesting new hypotheses going forward.  
  This study shows that Aspirin does not have an emotion blunting effect on positive or 
negative stimuli. This result is in contrast to studies of acetaminophen and ibuprofen’s effects, 
which do show emotion blunting (Acetaminophen: Durso, Luttrell, & Way, 2015; Ibuprofen: 
Durso, Keaveney, & Way, in preparation). This result provides us with evidence that COX-1 
inhibiting drugs are not involved in the blunting of emotional evaluations and emotional 
reactions. However, our current data suggests that Aspirin may in fact be having the opposite 
effect, namely enhancing evaluations and reactions to emotional stimuli, specifically negative 
stimuli. While no effect of Aspirin was seen in the evaluation of moderately pleasant or 
extremely pleasant stimuli, participants who took Aspirin rated neutral images as significantly 
more negative than participants on placebo and, while non-significant, participants who took 
Aspirin rated moderately unpleasant and extremely unpleasant stimuli more negatively than 
participants on placebo, as well. Participants given Aspirin also tended to have stronger 
emotional reaction to negative stimuli and a weaker emotional reaction to positive stimuli, 
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though these results were non-significant. These findings are in agreement with recent research 
done by Bradshaw et. al (In preparation) that has shown that the administration of Aspirin causes 
an increase in disgust sensitivity, with participants given Aspirin rating disgust images as more 
negative than participants on placebo. Altogether, this suggests that Aspirin may be enhancing 
our emotional reactions to, and evaluations of, negative stimuli, though no solid conclusions can 
be made at this point. Once further participants are able to be run, more conclusive results can be 
shown.       
Additionally, our findings cannot definitively show whether or not Aspirin is having an 
effect on the recognition of emotionally salient memory at this point. While currently there is no 
significant effect of drug condition on memory recognition, our results are close to significance 
and when collapsed into neutral, moderate, and extreme valances, participants given Aspirin 
have a significantly higher recognition of moderate images than participants on placebo. This 
suggests that Aspirin may enhance the recognition of emotionally salient memory, which would 
be expected if Aspirin is enhancing reactions to, and evaluations of, emotional stimuli. A 
correlation analysis showed that there was a significant relationship between the evaluations of 
extremely unpleasant images and the memory recognition of those extremely unpleasant images, 
however no other correlations were found between memory recognition and normative rating 
categories. Additionally, a mediation analysis showed that Aspirin’s effects on emotional ratings 
are not driving the relationship between Aspirin and memory recognition. The memory 
recognition task implemented in this experiment was a novel measure that was not previously 
performed in the studies our lab has conducted on acetaminophen or ibuprofen. Future research 
on acetaminophen and ibuprofen, and continuing research on Aspirin, will need to be conducted 
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in order to determine what effects, if any, they have on the recognition of emotionally salient 
images and how emotional ratings may affect this relationship.      
Some limitations of our work should be noted. As stated before, this study is currently 
underpowered, so no strong conclusions about Aspirin’s effects on emotional reactions to, and 
evaluations of, emotional stimuli, or its effect on memory recognition can be drawn at this point. 
Further, previous studies have indicated Aspirin’s role in blunting emotions (Ketterer, 1996; 
Karl, 2018; Savitz, 2018); however, this study as well as the work by Bradshaw et al. (In 
preparation) suggests that Aspirin does not have emotion blunting effects, and may in fact 
enhance emotional reactions and evaluations. Future work will be necessary in order to 
determine Aspirin’s potential psychological effects. For the memory recognition data, while 
recognition of extremely unpleasant images was enhanced compared to the other categories, we 
did not see the enhancement in the recognition of extremely pleasant images that we expected to, 
and the moderately unpleasant images had a lower recognition than was expected, as well. 
While this study shows that the COX-1 inhibitor Aspirin does not have blunting effects 
on emotion, it does suggest that Aspirin may have enhancing effects on the evaluation and 
emotional arousal of negative stimuli. This suggests that COX-1 and COX-2 potentially have 
opposite roles in emotional evaluation and emotional arousal, with the inhibition of COX-1 
causing emotion enhancement (at least towards negative stimuli) and COX-2 inhibition causing 
emotion blunting. Alternatively, these differential effects may be due to effects of these drugs on 
neurochemical pathways other than COX-1 or COX-2. For example, acetaminophen has effects 
on multiple drug systems including the cannabinoid, serotoninergic, and vanilloid (Graham, 
2013). Once the saliva samples are analyzed, determining if the change in salivary prostaglandin 
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levels is related to the emotional changes will help to clarify a role for the prostaglandin system 
in mediating these effects. 
Even if further research shows Aspirin does not have an effect on emotional evaluation or 
arousal, this research suggests the role of COX-2 in the blunting of emotional evaluations and 
arousal and future studies will need to be conducted in order to determine how COX-2 produces 
this psychological effect. However, this research shows that further research into the potential 
psychological side effects of Aspirin, especially in the domain of emotion, is needed. Since 
Aspirin has such widespread and still growing usage, it is important to understand all of the 
effects it has, not only physically, but psychologically, as well. Our data shows that additional 
research into Aspirin’s effects on emotional ratings and memory recognition may result in an 
interesting new understanding of how Aspirin effects the psychology of the people who use it, 
including the millions of people around the world who take the drug daily.      
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Images used in Emotional Image Rating Task 
 
All images from both the emotional image rating task and the memory recognition task 
were drawn from the previously published stimuli used in Leal et al. (2014), Schaller (2011) and 
the International Affective Picture System (Lang, 1995). The table below lists the set, image 
number, and valance category for each image used.  
Image Set Image Number Valance Category 
International Affective Picture System 1052 Extremely Unpleasant 
International Affective Picture System 1111 Extremely Unpleasant 
International Affective Picture System 1201 Extremely Unpleasant 
Leal et al. (2014) 10040a Extremely Unpleasant 
Leal et al. (2014) 10041a Extremely Unpleasant 
Leal et al. (2014) 10044a Extremely Unpleasant 
Schaller (2011) d6 Extremely Unpleasant 
Schaller (2011) d2 Extremely Unpleasant 
Schaller (2011) d4 Extremely Unpleasant 
Schaller (2011) d5 Extremely Unpleasant 
Leal et al. (2014) 10012a Extremely Unpleasant 
Leal et al. (2014) 10023a Extremely Unpleasant 
Leal et al. (2014) 10032a Extremely Unpleasant 
Leal et al. (2014) 10048a Extremely Unpleasant 
International Affective Picture System 6560 Extremely Unpleasant 
Leal et al. (2014) 10035a Extremely Unpleasant 
Leal et al. (2014) 10002a Extremely Unpleasant 
Leal et al. (2014) 10009a Extremely Unpleasant 
Leal et al. (2014) 10025a Extremely Unpleasant 
Leal et al. (2014) 10031a Extremely Unpleasant 
Leal et al. (2014) 10033a Extremely Unpleasant 
International Affective Picture System 3010 Extremely Unpleasant 
International Affective Picture System 3061 Extremely Unpleasant 
International Affective Picture System 3130 Extremely Unpleasant 
International Affective Picture System 3140 Extremely Unpleasant 
International Affective Picture System 3150 Extremely Unpleasant 
Leal et al. (2014) 10038a Extremely Unpleasant 
Leal et al. (2014) 10039a Extremely Unpleasant 
Leal et al. (2014) 10001a Extremely Unpleasant 
Leal et al. (2014) 10010a Extremely Unpleasant 
Leal et al. (2014) 10015a Extremely Unpleasant 
Leal et al. (2014) 10019a Extremely Unpleasant 
Leal et al. (2014) 10020a Extremely Unpleasant 
Leal et al. (2014) 10029a Extremely Unpleasant 
Leal et al. (2014) 10005a Extremely Unpleasant 
Schaller (2011) d10 Moderately Unpleasant 
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Schaller (2011) d3 Moderately Unpleasant 
International Affective Picture System 3250 Moderately Unpleasant 
International Affective Picture System 9594 Moderately Unpleasant 
Leal et al. (2014) 10013a Moderately Unpleasant 
Leal et al. (2014) 10043a Moderately Unpleasant 
International Affective Picture System 2457 Moderately Unpleasant 
Leal et al. (2014) 10022a Moderately Unpleasant 
Leal et al. (2014) 10028a Moderately Unpleasant 
Leal et al. (2014) 10006a Moderately Unpleasant 
Leal et al. (2014) 10016a Moderately Unpleasant 
Leal et al. (2014) 10021a Moderately Unpleasant 
Leal et al. (2014) 10036a Moderately Unpleasant 
Leal et al. (2014) 10045a Moderately Unpleasant 
Leal et al. (2014) 10046a Moderately Unpleasant 
Leal et al. (2014) 20003a Neutral 
Leal et al. (2014) 20010a Neutral 
Leal et al. (2014) 20012a Neutral 
Leal et al. (2014) 20015a Neutral 
Leal et al. (2014) 20016a Neutral 
Leal et al. (2014) 20017a Neutral 
Leal et al. (2014) 20020a Neutral 
Leal et al. (2014) 20022a Neutral 
Leal et al. (2014) 20023a Neutral 
Leal et al. (2014) 20025a Neutral 
Leal et al. (2014) 20026a Neutral 
Leal et al. (2014) 20028a Neutral 
Leal et al. (2014) 20029a Neutral 
Leal et al. (2014) 20031a Neutral 
Leal et al. (2014) 20035a Neutral 
Leal et al. (2014) 20037a Neutral 
Leal et al. (2014) 20038a Neutral 
Leal et al. (2014) 20041a Neutral 
Leal et al. (2014) 20043a Neutral 
Leal et al. (2014) 20048a Neutral 
Leal et al. (2014) 20006a Moderately Pleasant 
Leal et al. (2014) 20007a Moderately Pleasant 
Leal et al. (2014) 20014a Moderately Pleasant 
Leal et al. (2014) 20019a Moderately Pleasant 
Leal et al. (2014) 30009a Moderately Pleasant 
Leal et al. (2014) 30010a Moderately Pleasant 
Leal et al. (2014) 30025a Moderately Pleasant 
Leal et al. (2014) 30030a Moderately Pleasant 
Leal et al. (2014) 30031a Moderately Pleasant 
Leal et al. (2014) 30033a Moderately Pleasant 
Leal et al. (2014) 30034a Moderately Pleasant 
Leal et al. (2014) 30035a Moderately Pleasant 
International Affective Picture System 4800 Moderately Pleasant 
Leal et al. (2014) 30039a Moderately Pleasant 
International Affective Picture System 4647 Moderately Pleasant 
International Affective Picture System 4220 Extremely Pleasant 
International Affective Picture System 4290 Extremely Pleasant 
International Affective Picture System 4660 Extremely Pleasant 
International Affective Picture System 4670 Extremely Pleasant 
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International Affective Picture System 4680 Extremely Pleasant 
Leal et al. (2014) 30002a Extremely Pleasant 
Leal et al. (2014) 30003a Extremely Pleasant 
Leal et al. (2014) 30005a Extremely Pleasant 
Leal et al. (2014) 30006a Extremely Pleasant 
Leal et al. (2014) 30008a Extremely Pleasant 
Leal et al. (2014) 30011a Extremely Pleasant 
Leal et al. (2014) 30012a Extremely Pleasant 
Leal et al. (2014) 30013a Extremely Pleasant 
Leal et al. (2014) 30015a Extremely Pleasant 
Leal et al. (2014) 30016a Extremely Pleasant 
Leal et al. (2014) 30018a Extremely Pleasant 
Leal et al. (2014) 30019a Extremely Pleasant 
Leal et al. (2014) 30020a Extremely Pleasant 
Leal et al. (2014) 30022a Extremely Pleasant 
Leal et al. (2014) 30023a Extremely Pleasant 
Leal et al. (2014) 30026a Extremely Pleasant 
Leal et al. (2014) 30027a Extremely Pleasant 
Leal et al. (2014) 30028a Extremely Pleasant 
Leal et al. (2014) 30029a Extremely Pleasant 
Leal et al. (2014) 30036a Extremely Pleasant 
Leal et al. (2014) 30040a Extremely Pleasant 
Leal et al. (2014) 30041a Extremely Pleasant 
Leal et al. (2014) 30042a Extremely Pleasant 
Leal et al. (2014) 30045a Extremely Pleasant 
Leal et al. (2014) 30046a Extremely Pleasant 
Leal et al. (2014) 30047a Extremely Pleasant 
Leal et al. (2014) 30049a Extremely Pleasant 
Leal et al. (2014) 30051a Extremely Pleasant 
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Images used in Memory Recognition Task 
 
Image Set Image Number Valance Category Target/Foil/Lure 
Leal et. al (2014) 10012a Extremely Unpleasant Target 
Leal et. al (2014) 10039a Extremely Unpleasant Target 
Leal et. al (2014) 10041a Extremely Unpleasant Target 
Leal et. al (2014) 10009a Extremely Unpleasant Target 
Leal et. al (2014) 10015a Extremely Unpleasant Target 
Schaller (2012) d6 Extremely Unpleasant Target 
Schaller (2012) d5 Extremely Unpleasant Target 
International Affective Picture System 6560 Extremely Unpleasant Target 
Leal et. al (2014) 10005a Extremely Unpleasant Target 
Leal et. al (2014) 10043a Moderately Unpleasant Target 
Leal et. al (2014) 10046a Moderately Unpleasant Target 
Leal et. al (2014) 10022a Moderately Unpleasant Target 
Leal et. al (2014) 10013a Moderately Unpleasant Target 
Leal et. al (2014) 10016a Moderately Unpleasant Target 
Leal et. al (2014) 10036a Moderately Unpleasant Target 
Schaller (2012) d3 Moderately Unpleasant Target 
Schaller (2012) d10 Moderately Unpleasant Target 
International Affective Picture System 2457 Moderately Unpleasant Target 
Leal et. al (2014) 20029a Neutral Target 
Leal et. al (2014) 20026a Neutral Target 
Leal et. al (2014) 20025a Neutral Target 
Leal et. al (2014) 20028a Neutral Target 
Leal et. al (2014) 20022a Neutral Target 
Leal et. al (2014) 20003a Neutral Target 
Leal et. al (2014) 20010a Neutral Target 
Leal et. al (2014) 20012a Neutral Target 
Leal et. al (2014) 20017a Neutral Target 
International Affective Picture System 4647 Moderately Pleasant Target 
Leal et. al (2014) 30034a Moderately Pleasant Target 
International Affective Picture System 4800 Moderately Pleasant Target 
Leal et. al (2014) 30035a Moderately Pleasant Target 
Leal et. al (2014) 30010a Moderately Pleasant Target 
Leal et. al (2014) 20007a Moderately Pleasant Target 
Leal et. al (2014) 20006a Moderately Pleasant Target 
Leal et. al (2014) 30009a Moderately Pleasant Target 
Leal et. al (2014) 30030a Moderately Pleasant Target 
International Affective Picture System 4220 Extremely Pleasant Target 
Leal et. al (2014) 30003a Extremely Pleasant Target 
International Affective Picture System 4660 Extremely Pleasant Target 
Leal et. al (2014) 30051a Extremely Pleasant Target 
International Affective Picture System 4290 Extremely Pleasant Target 
Leal et. al (2014) 30012a Extremely Pleasant Target 
International Affective Picture System 4670 Extremely Pleasant Target 
Leal et. al (2014) 30018a Extremely Pleasant Target 
Leal et. al (2014) 30019a Extremely Pleasant Target 
Leal et. al (2014) 10023c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10005c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10035c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10002c Extremely Unpleasant High Similarity Lure 
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Leal et. al (2014) 10031c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10001c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10038c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10029c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10025c Extremely Unpleasant High Similarity Lure 
Leal et. al (2014) 10043c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10013c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10046c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10045c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10021c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10022c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10046c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10036c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 10006c Moderately Unpleasant High Similarity Lure 
Leal et. al (2014) 20037c Neutral High Similarity Lure 
Leal et. al (2014) 20029c Neutral High Similarity Lure 
Leal et. al (2014) 20025c Neutral High Similarity Lure 
Leal et. al (2014) 20043c Neutral High Similarity Lure 
Leal et. al (2014) 20031c Neutral High Similarity Lure 
Leal et. al (2014) 20035c Neutral High Similarity Lure 
Leal et. al (2014) 20003c Neutral High Similarity Lure 
Leal et. al (2014) 20010c Neutral High Similarity Lure 
Leal et. al (2014) 20015c Neutral High Similarity Lure 
Leal et. al (2014) 20019c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30034c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 20014c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30033c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30039c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30035c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 20006c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30009c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30010c Moderately Pleasant High Similarity Lure 
Leal et. al (2014) 30019c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30013c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30016c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30023c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30046c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30008c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30002c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30005c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 30020c Extremely Pleasant High Similarity Lure 
Leal et. al (2014) 10032b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10039b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10048b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10031b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10040b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10020b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10012b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10023b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10035b Extremely Unpleasant Low Similarity Lure 
Leal et. al (2014) 10013b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10036b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10006b Moderately Unpleasant Low Similarity Lure 
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Leal et. al (2014) 10016b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10021b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10028b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10043b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10022b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 10046b Moderately Unpleasant Low Similarity Lure 
Leal et. al (2014) 20048b Neutral Low Similarity Lure 
Leal et. al (2014) 20026b Neutral Low Similarity Lure 
Leal et. al (2014) 20025b Neutral Low Similarity Lure 
Leal et. al (2014) 20022b Neutral Low Similarity Lure 
Leal et. al (2014) 20017b Neutral Low Similarity Lure 
Leal et. al (2014) 20016b Neutral Low Similarity Lure 
Leal et. al (2014) 20003b Neutral Low Similarity Lure 
Leal et. al (2014) 20010b Neutral Low Similarity Lure 
Leal et. al (2014) 20012b Neutral Low Similarity Lure 
Leal et. al (2014) 30010b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 20006b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 30030b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 20007b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 20014b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 30031b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 30009b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 30033b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 30035b Moderately Pleasant Low Similarity Lure 
Leal et. al (2014) 30003b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30011b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30040b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30049b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30018b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30029b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30002b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30036b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 30026b Extremely Pleasant Low Similarity Lure 
Leal et. al (2014) 40041a Extremely Unpleasant Foil 
Leal et. al (2014) 40038a Extremely Unpleasant Foil 
Leal et. al (2014) 40006a Extremely Unpleasant Foil 
Leal et. al (2014) 40009a Extremely Unpleasant Foil 
Leal et. al (2014) 40022a Extremely Unpleasant Foil 
Leal et. al (2014) 40035a Extremely Unpleasant Foil 
Leal et. al (2014) 40002a Extremely Unpleasant Foil 
Leal et. al (2014) 40010a Extremely Unpleasant Foil 
Leal et. al (2014) 40011a Extremely Unpleasant Foil 
Leal et. al (2014) 40007a Moderately Unpleasant Foil 
Leal et. al (2014) 40013a Moderately Unpleasant Foil 
Leal et. al (2014) 40028a Moderately Unpleasant Foil 
Leal et. al (2014) 40031a Moderately Unpleasant Foil 
Leal et. al (2014) 40044a Moderately Unpleasant Foil 
Leal et. al (2014) 40029a Moderately Unpleasant Foil 
Leal et. al (2014) 40008a Moderately Unpleasant Foil 
Leal et. al (2014) 40012a Moderately Unpleasant Foil 
Leal et. al (2014) 40015a Moderately Unpleasant Foil 
Leal et. al (2014) 50005a Neutral Foil 
Leal et. al (2014) 50007a Neutral Foil 
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Leal et. al (2014) 50010a Neutral Foil 
Leal et. al (2014) 50014a Neutral Foil 
Leal et. al (2014) 50016a Neutral Foil 
Leal et. al (2014) 50042a Neutral Foil 
Leal et. al (2014) 50013a Neutral Foil 
Leal et. al (2014) 50017a Neutral Foil 
Leal et. al (2014) 50018a Neutral Foil 
Leal et. al (2014) 60001a Moderately Pleasant Foil 
Leal et. al (2014) 60003a Moderately Pleasant Foil 
Leal et. al (2014) 60011a Moderately Pleasant Foil 
Leal et. al (2014) 60019a Moderately Pleasant Foil 
Leal et. al (2014) 60002a Moderately Pleasant Foil 
Leal et. al (2014) 60004a Moderately Pleasant Foil 
Leal et. al (2014) 60017a Moderately Pleasant Foil 
Leal et. al (2014) 60032a Moderately Pleasant Foil 
Leal et. al (2014) 60041a Moderately Pleasant Foil 
Leal et. al (2014) 60048a Extremely Pleasant Foil 
Leal et. al (2014) 60043a Extremely Pleasant Foil 
Leal et. al (2014) 60038a Extremely Pleasant Foil 
Leal et. al (2014) 60033a Extremely Pleasant Foil 
Leal et. al (2014) 60027a Extremely Pleasant Foil 
Leal et. al (2014) 60010a Extremely Pleasant Foil 
Leal et. al (2014) 60039a Extremely Pleasant Foil 
Leal et. al (2014) 60024a Extremely Pleasant Foil 
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Questionnaires 
Background Measures 



































How many hours of actual sleep did you get? (This may be different than the number of 





Approximately how long ago did you last eat?  ____________ 
 
Was it a (indicate one): 





Have you done any aerobic exercise today?                                   Yes           No 
 
If yes, how many minutes? _____________ 
 
If yes, how long ago (in hours)? _____________ 
 
10.  
 On an average week, how many days do you do aerobic exercise? __________ 
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In general, would you say that your health is (indicate one): 
 
Excellent            Very Good                Good                   Fair                  Poor 
 
Please answer the 
following 3 questions by 








Over the last couple of 
days, I have not been 
feeling well. 
1 2 3 4 5 
 
3. 
Lately, I have been 
feeling a little under 
the weather 




I have felt sick within 
the last week. 
 
1 2 3 4 5 
 
5. 
When was the last time you had a cold, flu, dental infection, or other infection? 
____Today  
____A couple of days ago  
____A week ago 
____A couple of weeks ago 
____A month ago 
____A few months ago 
____A year or more ago 
 
6.   
Did you seek medical care for any sort of cold, flu, or infection in the last 3 months?      Yes        
No 
 
If yes, how many times in the last 3 months did you go to the health center for an 
illness?__________________ 
7.   
Did you take any over-the-counter or prescription medications for a cold, flu, or          Yes        
No 
any infection in the last 3 months? 
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If yes, what medications_______________________________________________ 
 
 Please answer the following questions by circling a response on the right: 
 
 
1.  In the box below, please list all medications AND vitamins or supplements you are currently 
taking, including pills, patches, lotions or injections. Medications can be prescription medications 
or over-the-counter medications. Be sure to include the NAME, DOSE, AMOUNT and FREQUENCY 
you take the medications or supplements, putting a comma between each one. If the medication 
or supplement does not have a particular dose, please put "NA" after name and before frequency. 
See examples below. 
 
Example 1: Oxytrol 3.9 mg 1 patch every 4 days, Femgest progesterone cream no dosage apply to 
hands once per day, Synthroid 75 mcg 1 pill once per day. 
 
Example 2: Timoptic 0.25% 2 drops per eye twice per day, Saw Palmetto 160 mg 1 pill twice per day, 
Zocor 20 mg each night. 
 
Example 3: Calcium 333mg/pill 3 pills per day, Vitamin C 500mg 1 pill per day, Vitamin D 1000mg 1 























How often do you typically use marijuana? (indicate one) 
 
___ Almost every day                                  ___ At least once a month 
___ Several times a week                             ___ Several times a year 
___ At least once a week                              ___ At least once a year 
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How long ago did you last use marijuana?  (If in the last day, please indicate the number of 
hours. If not record the number of days, months, or years.) 
 
Hours:__________  Days: __________  Months: __________  Years: __________ 
 




How many cigarettes per day do you smoke (indicate one response)? 
 





If you smoke, how long has it been since your last cigarette? (Please indicate the number of 
minutes and hours.) 
 




When was the last time you consumed an alcoholic beverage?   (If in the last day, please 
indicate the number of hours. If not record the number of days, months, or years.) 
 
Hours:__________  Days: __________  Months: __________  Years: __________ 
 
_____I do not drink alcohol. 
 
 













2 - 4 times a 
month  
2 – 3 
times a 
week 
4 or more 











1 or 2 3 or 4 5 or 6 7 to 9 10 or 
more 
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Do you have arthritis or any immune disorders that might lead to  





Do you have any chronic illnesses that affect the  
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Political Ideology (Wilson, 1968) 
G.D. Wilson, J.R. Patterson, A new measure of conservatism, Br. J. Soc. Clin.Psychol. 7 (1968) 264–269. 
Mofied by Mills, M., Gonzalez, F. J., Giuseffi, K., Sievert, B., Smith, K. B., Hibbing, J. R., & 
Dodd, M. D. (2016). Political conservatism predicts asymmetries in emotional scene 
memory. Behavioural brain research, 306, 84–90. 
 








agree with (4) strongly agree 
with (5) 
school prayer 
(1)  o  o  o  o  o  
pacifism (2)  




o  o  o  o  o  
death penalty 
(4)  o  o  o  o  o  
government-
arranged 
healthcare (5)  
o  o  o  o  o  
premarital sex 
(6)  o  o  o  o  o  
gay marriage 
(7)  o  o  o  o  o  
abortion rights 
(8)  o  o  o  o  o  
evolution (9)  
o  o  o  o  o  
biblical truth 
(10)  o  o  o  o  o  
increased 
welfare 
spending (11)  
o  o  o  o  o  
protecting gun 
rights (12)  o  o  o  o  o  
increasing 
military 
spending (13)  
o  o  o  o  o  
government 
regulation of 
business (14)  




o  o  o  o  o  
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foreign aide 
(16)  o  o  o  o  o  
lowering taxes 
(17)  o  o  o  o  o  
stem cell 
research (18)  o  o  o  o  o  
abstinence-
only sex 
education (19)  




suspects (20)  
o  o  o  o  o  
 
When it comes to politics in general, do you usually think of yourself as liberal, moderate, or 
conservative? 
o very liberal  (1)  
o liberal  (2)  
o somewhat liberal  (3)  
o moderate  (4)  
o somewhat conservative  (5)  
o conservative  (6)  
o very conservative  (7)  
 
 
In general, I consider myself a: 
o Democrat  (1)  
o Republican  (2)  
o Libertarian  (3)  
o Other  (4)  
 
 
When it comes to politics in general, do you usually think of yourself as liberal, moderate, conservative 
















1 2 3 4 5 6 7 
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1 2 3 4 5 6 7 
 
















1 2 3 4 5 6 7 
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Emotionality Measures  
Domain Specific Risk Taking (Blais & Weber, 2006) 
Blais, A. & Weber, E. U. (2006). A domain-specific risk-taking (DOSPERT) scale for adult populations. 
Judgment and Decision Making, 1(1): 33-47. 
 
Risk Perception 
People often see some risk in situations that contain uncertainty about what the outcome or 
consequences will be and for which there is the possibility of negative consequences.  However, 
riskiness is a very personal and intuitive notion, and we are interested in your gut level assessment of 
how risky each situation or behavior is. For each of the following statements, please indicate how risky 
you perceive each situation. Provide a rating from Not at all Risky to Extremely Risky, using the following 
scale: 
1 Not at all Risky  2 Slightly Risky  3 Somewhat Risky  4 Moderately Risky  5 Risky  6 Very Risky  7Extremely Risky 
Expected Benefits 
For each of the following statements, please indicate the benefits you would obtain from each  
situation. Provide a rating from 1 to 7, using the following scale: 
1 No Benefits at all       2           3          4 Moderate Benefits        5          6        7 Great Benefits 
Items 
 
1.Admitting that your tastes are different from those of a friend. (S) 
2.Going camping in the wilderness. (R) 
3.Betting a day’s income at the horse races. (F/G) 
4.Investing 10% of your annual income in a moderate growth diversified fund. (F/I) 
5.Drinking heavily at a social function. (H/S) 
6.Taking some questionable deductions on your income tax return. (E)  
7.Disagreeing with an authority figure on a major issue. (S) 
8.Betting a day’s income at a high-stake poker game. (F/G)  
9.Having an affair with a married man/woman. (E) 
10.Passing off somebody else’s work as your own. (E) 
11.Going down a ski run that is beyond your ability. (R) 
12.Investing 5% of your annual income in a very speculative stock. (F/I) 
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13.Going whitewater rafting at high water in the spring. (R)  
14.Betting a day’s income on the outcome of a sporting event  (F/G) 
15.Engaging in unprotected sex. (H/S) 
16.Revealing a friend’s secret to someone else. (E) 
17.Driving a car without wearing a seat belt. (H/S)  
18.Investing 10% of your annual income in a new business venture. (F/I)  
19.Taking a skydiving class. (R)  
20.Riding a motorcycle without a helmet. (H/S)  
21.Choosing a career that you truly enjoy over a more secure one. (S) 
22.Speaking your mind about an unpopular issue in a meeting at work. (S) 
23.Sunbathing without sunscreen. (H/S) 
24.Bungee jumping off a tall bridge.  (R) 
25.Piloting a small plane. (R) 
26.Walking home alone at night in an unsafe area of town. (H/S) 
27.Moving to a city far away from your extended family. (S) 
28.Starting a new career in your mid-thirties. (S) 
29.Leaving your young children alone at home while running an errand. (E)  
30.Not returning a wallet you found that contains $200. (E)  
Note. E = Ethical, F = Financial, H/S = Health/Safety, R = Recreational, and S = Social. 
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Toronto Alexithymia Scale 
Bagby, R. M., Parker, J. D. A. & Taylor, G. J. (1994). The twenty-item Toronto Alexithymia Scale-I. Item 
selection and cross-validation of the factor structure. Journal of Psychosomatic Research, 38, 23-32. 
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Highly Sensitive Persons Scale (Pluess, 2018) 
Pluess, M., Assary, E., Lionetti, F., Lester, K. J., Krapohl, E., Aron, E. N., & Aron, A. (2018). Environmental 
sensitivity in children: Development of the Highly Sensitive Child Scale and identification of 
sensitivity groups. Developmental psychology, 54(1), 51. 
 
 
1. I find it unpleasant to have a lot going on at once  
2. Some music can make me really happy 
3. I love nice tastes  
4. Loud noises make me feel uncomfortable 
5. I am annoyed when people try to get me to do too many things at once 
6. I notice it when small things have changed in my environment 
7. I get nervous when I have to do a lot in little time  
8. I love nice smells 
9. I don’t like watching TV programs that have a lot of violence in them 
10. I don’t like loud noises 
11. I don’t like it when things change in my life 
12 When someone observes me, I get nervous. This makes me perform worse than normal. 
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The Positive and Negative Affectivity Scale Questionnaire (PANAS; Watson, Clark, & Tellegan, 1988)  
Watson D., Clark, L. A., & Tellegan, A. (1988). Development and validation of brief measures of positive 
and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54(6): 1063-
1070. 
 
This scale consists of a number of words that describe different feelings and emotions. Read 
each item and then list the number from the scale below next to each word.  Indicate to what 
extent you feel this way right now, that is, at the present moment OR indicate the extent you 
have felt this way over the past week (circle the instructions you followed when taking this 
measure) 
 
Very Slightly or Not at All    A Little    Moderately       Quite a Bit             Extremely 
            1         2            3                          4                           5 
_______ 1. Interested    _______ 11. Irritable 
_______ 2. Distressed    _______ 12. Alert 
_______ 3. Excited    _______ 13. Ashamed 
_______ 4. Upset    _______ 14. Inspired 
_______ 5. Strong    _______ 15. Nervous 
_______ 6. Guilty    _______ 16. Determined 
_______ 7. Scared    _______ 17. Attentive 
_______ 8. Hostile    _______ 18. Jittery 
_______ 9. Enthusiastic   _______ 19. Active 
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Tybur 3 Domain Disgust Questionnaire (Tybur, 2009) 
Tybur, J. M., Lieberman, D., & Griskevicius, V. (2009). Microbes, mating, and morality: Individual 
differences in three functional domains of disgust. Journal of Personality and Social 
Psychology, 97: 103–122. 
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Revised SocioSexual Orientation Inventory (Penke & Asendorpf, 2008) 
Penke, L., & Asendorpf, J. B. (2008). Beyond global sociosexual orientations: A more differentiated look 
at sociosexuality and its effects on courtship and romantic relationships. Journal of Personality 
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Mental Health Measures 
Patient Health Questionnaire (PHQ-9; Kroenke & Spitzer, 2002)  
Kroenke K., Spitzer R.L. (2002). The PHQ-9: a new depression and diagnostic severity measure. Psychiatr 
Ann, 32: 509-21.  
(Note: The question about suicide has been deleted). 
Over the last 2 weeks, how often have you been bothered by any of the following problems? (0 = not at 
all; several days = 1; More than half the days = 2; Nearly every day = 3) 
1. Little interest or pleasure in doing things 
2. Feeling down, depressed, or hopeless 
3. Trouble falling or staying asleep, or sleeping too much 
4. Feeling tired or having little energy 
5. Poor appetite or overeating 
6. Feeling bad about yourself/failure 
7. Trouble concentrating on things 
8. Moving or speaking so slowly that other people could have noticed. Or being fidgety/restless. 
 
If you checked off any problems, how difficult have these problems made it for you to do your work, 
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PAI-BOR (Morey, 1991) 




Read each statement and decide if it is an accurate statement about you.  Circle your answer after each 
statement.  
 
False, not at all true – F    Slightly True – ST     Mainly True – MT    Very True - VT 
 
 
1.  My mood can shift quite suddenly.      F ST MT VT 
2. My attitude about myself changes a lot.    F ST MT VT 
3. My relationships have been stormy.    F ST MT VT 
4. My moods get quite intense.      F ST MT VT 
5. Sometimes I feel terribly empty inside.   F ST MT VT 
6. I want to let certain people know how much they’ve hurt me.  F ST MT VT 
7. My mood is very steady.       F ST MT VT 
8. I worry a lot about other people leaving me.     F ST MT VT 
9. People once close to me have let me down.   F ST MT VT 
10. I have little control over my anger.    F ST MT VT 
11. I often wonder what I should do with my life.    F ST MT VT 
12. I rarely feel very lonely.      F ST MT VT 
13. I sometimes do things so impulsively that I get into trouble.  F ST MT VT 
14. I’ve always been a pretty happy person.   F ST MT VT 
15. I can’t handle separation from those close to me very well.   F ST MT VT 
16. I’ve made some real mistakes in the people I’ve picked as friends.  F ST MT VT 
17. When I’m upset, I typically do something to hurt myself.   F ST MT VT 
18. I’ve had times when I was so mad I couldn’t do enough to express my anger. F ST MT VT 
19. I don’t get bored very easily.    F ST MT VT 
20. Once someone is my friend, we stay friends.    F ST MT VT 
21. I’m too impulsive for my own good.     F ST MT VT 
22. I spend money too easily.       F ST MT VT 
23. I’m a reckless person.     F ST MT VT 
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Family Questionnaire (Felitti, 1997) 
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., ... & Marks, J. S. 
(1997). Relationship of childhood abuse and household dysfunction to many of the leading 
causes of death in adults: The Adverse Childhood Experiences (ACE) Study. American journal of 
preventive medicine, 56(6), 774-786. 
 
 
Please answer these questions recognitioning back to your childhood using the scale: 
1 2 3 4 5 
Not at All    Very Often 
 
1. How often did a parent or other adult in the household make you feel that you were loved, supported 
and cared for? 
2. How often did a parent or other adult in the household swear at you, insult you, put you down, or act  
3. How often did a parent or other adult in the household express physical affection for you, such as  
4. How often did a parent or other adult in the household push, grab, shove, or slap you? 
5. How often would you say that a parent or other adult in the household behaved violently toward a  
6. How often would you say there as quarreling, arguing, or shouting between your parents? 
7. How often would you say there was quarreling, arguing, or shouting between you’re a parent and you? 
8. How often would you say there was quarreling, arguing, or shouting between a parent and one of  
9. How often would you say there was quarreling, arguing, or shouting between your sibling(s) and you? 
10. Would you say the household you grew up in was chaotic and disorganized? 
11. In your childhood, did you live with anyone who was a problem drinker or alcoholic, or who used street 
drugs? 
12. Would you say that the household you grew up in was well-organized and well-managed? 
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Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983) 
Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of  




0 = Never 1= Almost Never 2=Sometimes  3=Fairly Often  4=Very Often 
In the last month: 
1. How often have you been upset because of something that happened unexpectedly? 
2. How often have you felt that you were unable to control the important things in your life? 
3. How often have you felt nervous and “stressed”? 
4. How often have you felt confident about your ability to handle your personal problems? 
5. How often have you felt that things were going your way? 
6. How often have you found that you could not cope with all the things you had to do? 
7. How often have you been able to control irritations in your life? 
8. How often have you felt that you were on top of things? 
9. How often have you been angered because of things that were outside of your control? 
10. How often have you felt difficulties were piling up so high that you could not overcome them? 
 
 
